Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Recruiting · NCT04501406 · Registry updated 2025-04-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Low-Dose Pioglitazone in Patients With NASH (AIM 2) | Digestive System Diseases, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus | Recruiting | Phase 2 | 2025-04-04 | NCT04501406 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
| University of Florida | 315 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Florida | Gainesville | United States | 144 |